Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03808909
Other study ID # 18-280
Secondary ID 5U54MD004811-10
Status Completed
Phase N/A
First received
Last updated
Start date February 6, 2019
Est. completion date July 19, 2019

Study information

Verified date November 2022
Source University of New Mexico
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will determine the feasibility of offering expanded continuous labor support by trauma- and addiction-trained medical paraprofessionals (i.e. doulas) at no cost to pregnant women receiving care for substance use disorders (SUD). The long-term goal of this transdisciplinary multilevel intervention is ultimately to reduce a major existing behavioral health disparity in the state. This cross-campus multi-disciplinary collaboration, is in partnership with Young Women United (a research and policy organization in NM) and doulas of the UNM Birth Companion Program. Through this partnership, women receiving combined OB/SUD treatment at the Milagro Program at UNMHSC will be offered expanded doula services.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date July 19, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - at least 18 years old - able to participate in informed consent - able to read, write, and speak English - gestation of at least 26 weeks at baseline (necessary because of short duration of study) - plan to give birth at UNM. Exclusion Criteria: - active psychosis - current incarceration - identified by medical staff as unable for medical reasons to currently participate in the study - not interested in having doula support

Study Design


Intervention

Other:
Continuous Labor Support
Participants in the intervention condition will be assigned a doula who is a lay person trained to provide emotional and practical support to individuals throughout labor and delivery.

Locations

Country Name City State
United States University of New Mexico Albuquerque New Mexico

Sponsors (2)

Lead Sponsor Collaborator
University of New Mexico National Institute on Minority Health and Health Disparities (NIMHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Percentage of Days With Drinking or Substance Use Using the timeline followback we will calculate average percentage of days of alcohol or other substance use for each group from pregnancy recognition to the 2 week follow-up. 2 week postpartum follow-up assessment
Other Mother's Autonomy During Birth Mother's Autonomy in Decision Making Questionnaire Higher scores indicate more autonomy (better outcome) Scale range = 7 - 42 queries feelings during labor and birth but is administered at 2 week follow-up
Other Postpartum Depression Edinburgh Postpartum Depression Scale Higher scores are a worse outcome Scale range = 0-30 2 week postpartum follow-up assessment
Other Breastfeeding Update Using a study specific form we will calculate the number of participants who attempted breastfeeding after the birth of the baby 2 week postpartum follow-up assessment
Other Neonatal Abstinence Syndrome NAS diagnosis neonatal
Other Length of NICU Stay Average length of time that the infant remains hospitalized in the NICU after the birth from birth through study completion, an average of 3 months
Other Social Support - NIH Toolbox Average score for social support on NIH toolbox Total of Emotional, Friend, and Instrumental Social support scales Higher scores indicated a better outcome Scale range = 24 - 120 2 week postpartum follow-up assessment
Primary Number of Participants Who Remain in the Study Number of participants who complete the 2 week follow-up 2 week postpartum follow-up assessment
Secondary Alternative Birth Outcome Number of participants with preterm, c-section, fetal demise, still birth, or other potential birth outcomes birth
Secondary Postpartum Posttraumatic Stress Disorder Checklist PTSD Checklist - 5 (PCL-5) Higher scores indicate a worse outcome Range of scale = 0 - 80 2 week postpartum follow-up assessment
Secondary Participant Satisfaction Study specific participant satisfaction - debriefing form - qualitative data. No qualitative analyses have been conducted with this data. 2 week postpartum follow-up assessment
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3